Pulse Biosciences names chief strategy officer

Pulse Biosciences (NSDQ:PLSE) announced today that it appointed Mitchell E. Levinson to its newly created chief strategy officer role.

Hayward, Calif.-based Pulse Biosciences said in a news release that Levinson’s new role, which begins effective immediately, will be held in addition to his position as a member of the company’s board of directors.

Pulse Biosciences develops the CellFX system, powered by nano-pulse stimulation, for the delivery of nanosecond pulses of electrical energy designed to clear cells while sparing adjacent non-cellular tissue.

“As a board member and medical device industry veteran with a track record of successfully bringing new technologies and products to market across a variety of medical specialties, Mitch’s insights have benefitted Pulse Biosciences for over five years,” Pulse Biosciences president & CEO Darrin Uecker said in the release. “We are thrilled to add him to the executive leadership team at this cr…

Read more
  • 0